Latest Regulatory News

Hydralyte USA has placed 39.5 million shortfall shares at $0.01 each, boosting total funds raised under its recent Rights Issue to nearly $559,000. The move strengthens the company’s capital position amid ongoing growth efforts.

L1 Capital and Platinum Asset Management have formalised their merger with a binding agreement, promising continuity for L1 Long Short Fund's management and strategy.

Marquee Resources has identified significant gold anomalies across its 106 km² Yindi Gold Project in Western Australia, backed by a thorough review of historical drilling data. The company plans targeted drilling to validate promising intercepts near major gold operations.

archTIS Limited has successfully raised $7.5 million through a share placement, aiming to fuel its international growth strategy focused on U.S. market expansion, strategic partnerships, and product development.

Platinum Asset Management and L1 Capital have agreed to merge, creating a combined entity managing approximately A$16.5 billion in assets. The deal promises strategic diversification, cost synergies, and significant earnings accretion for shareholders.

Argent BioPharma has begun supplying its EU-GMP cannabinoid API for drug-resistant epilepsy treatment at University Medical Centre Ljubljana, marking a key clinical and regulatory milestone in Europe.

Kincora Copper announces a C$4 million private placement backed by prominent North American investors, alongside a planned 10-for-1 share consolidation to accelerate exploration at its Condobolin project.

Sun Silver Limited has obtained regulatory approval for 90 additional drill pads at its Maverick Springs Silver-Gold Project in Nevada, enabling uninterrupted drilling to support resource upgrades and metallurgical testing through 2025.

Nova Minerals has filed a Form F-1 registration statement with the U.S. SEC for a secondary offering of its American Depositary Shares, aiming to raise capital for advancing its Estelle Project in Alaska.

BlinkLab has expanded its pivotal FDA autism diagnostic trial by adding the University of Nebraska Medical Center as a second U.S. clinical site, advancing toward broader validation and regulatory clearance.

Medallion Metals reports standout gold and copper assays from Harbour View infill drilling, reinforcing resource confidence ahead of a July update and advancing its strategic Forrestania acquisition.

Renascor Resources has expanded its Marree project with a farm-in deal securing a standout uranium-copper prospect and is progressing drilling at Bulloo Creek alongside advancing its flagship battery anode materials facility.